Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


30.01.2017

4 Acta Cytol
2 Am J Clin Pathol
1 Am J Pathol
7 Anticancer Res
1 BMC Cancer
1 Breast Cancer
2 Breast Cancer Res
2 Breast Cancer Res Treat
7 Breast J
1 Cancer
2 Cancer Lett
3 Cancer Res
1 Clin Breast Cancer
2 Clin Cancer Res
1 Clin Exp Metastasis
1 Eur J Surg Oncol
1 Gene
1 Int J Cancer
3 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
1 J Natl Cancer Inst
1 J Nucl Med
2 N Engl J Med
1 NPJ Breast Cancer
1 Oncogene
2 Oncol Rep
2 Oncology
8 PLoS One
1 Pol J Radiol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Cytol

  1. TRICHIA H, Ignatova O, Lekka J, Papazian M, et al
    Malignant Myoepithelioma of the Breast Clinically and Histologically Masquerading as Angiosarcoma: Cytological Findings and Review of the Literature.
    Acta Cytol. 2016;60:260-6.
    PubMed     Text format     Abstract available

  2. HOU Y, Shen R, Chaudhary S, Gao F, et al
    Correlation of Expression of Breast Biomarkers in Primary and Metastatic Breast Carcinomas: A Single-Institution Experience.
    Acta Cytol. 2016;60:481-489.
    PubMed     Text format     Abstract available

  3. PASCHOALINI RB, Mucha Dufloth R, Moraes Neto FA, Schmitt FC, et al
    Cytological Criteria for Predicting the Luminal Phenotype of Breast Carcinoma.
    Acta Cytol. 2016;60:406-412.
    PubMed     Text format     Abstract available

  4. HELAL TE, Shash LS, Saad El-Din SA, Saber SM, et al
    Idiopathic Granulomatous Mastitis: Cytologic and Histologic Study of 65 Egyptian Patients.
    Acta Cytol. 2016;60:438-444.
    PubMed     Text format     Abstract available


    Am J Clin Pathol

  5. HOU Y, Nitta H, Li Z
    HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer.
    Am J Clin Pathol. 2017 Jan 21. pii: aqw211. doi: 10.1093.
    PubMed     Text format     Abstract available

  6. SERDY KM, Leone JP, Dabbs DJ, Bhargava R, et al
    Male Breast Cancer: A Single-Institution Clinicopathologic and Immunohistochemical Study.
    Am J Clin Pathol. 2017 Jan 24. pii: aqw207. doi: 10.1093.
    PubMed     Text format     Abstract available


    Am J Pathol

  7. LAZO PA
    Is Centrosomal Protein 70, a Centrosomal Protein with New Roles in Breast Cancer Dissemination and Metastasis, a Facilitator of Epithelial-Mesenchymal Transition?
    Am J Pathol. 2017 Jan 18. pii: S0002-9440(17)30042.
    PubMed     Text format     Abstract available


    Anticancer Res

  8. LUCZYNSKA E, Heinze S, Adamczyk A, Rys J, et al
    Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Anticancer Res. 2016;36:4359-66.
    PubMed     Text format     Abstract available

  9. SHAVERDIAN N, Wang J, Levin-Epstein R, Schaue D, et al
    Pro-inflammatory State Portends Poor Outcomes with Stereotactic Radiosurgery for Brain Metastases.
    Anticancer Res. 2016;36:5333-5337.
    PubMed     Text format     Abstract available


  10. Breast Disease. Management and Therapies.
    Anticancer Res. 2016;36:4376.
    PubMed     Text format    

  11. DO SI, Yoon G, Kim HS, Kim K, et al
    Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast.
    Anticancer Res. 2016;36:4873-82.
    PubMed     Text format     Abstract available

  12. STAHL JM, Hong JC, Lester-Coll NH, Kann BH, et al
    Chest Wall Deformity in the Radiation Oncology Clinic.
    Anticancer Res. 2016;36:5295-5300.
    PubMed     Text format     Abstract available

  13. STRIEN L, Joensuu K, Heikkila P, Leidenius MH, et al
    Different Expression Patterns of CXCR4, CCR7, Maspin and FOXP3 in Luminal Breast Cancers and Their Sentinel Node Metastases.
    Anticancer Res. 2017;37:175-182.
    PubMed     Text format     Abstract available

  14. FUJII T, Yajima R, Kuwano H
    Implications of Long-term Indwelling of Tissue Expander in Breast Reconstruction: Risk of Expander Rupturing.
    Anticancer Res. 2016;36:4337-40.
    PubMed     Text format     Abstract available


    BMC Cancer

  15. AUGUSTIN LS, Libra M, Crispo A, Grimaldi M, et al
    Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial.
    BMC Cancer. 2017;17:69.
    PubMed     Text format     Abstract available


    Breast Cancer

  16. INOUE M, Nakagomi H, Nakada H, Furuya K, et al
    Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
    Breast Cancer. 2017 Jan 20. doi: 10.1007/s12282-017-0753.
    PubMed     Text format     Abstract available


    Breast Cancer Res

  17. MULLOOLY M, Yang HP, Falk RT, Nyante SJ, et al
    Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients.
    Breast Cancer Res. 2017;19:8.
    PubMed     Text format     Abstract available

  18. ELLINGJORD-DALE M, Vos L, Tretli S, Hofvind S, et al
    Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
    Breast Cancer Res. 2017;19:10.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  19. VALLA M, Engstrom MJ, Ytterhus B, Hansen AK, et al
    FGD5 amplification in breast cancer patients is associated with tumour proliferation and a poorer prognosis.
    Breast Cancer Res Treat. 2017 Jan 25. doi: 10.1007/s10549-017-4125.
    PubMed     Text format     Abstract available

  20. DEN BROK WD, Speers CH, Gondara L, Baxter E, et al
    Response to "Do metastasis-free interval less or more than 24 months for recurrent metastatic breast cancer and primary surgery for de novo metastatic breast cancer matter for survival?"
    Breast Cancer Res Treat. 2017 Jan 21. doi: 10.1007/s10549-017-4114.
    PubMed     Text format    


    Breast J

  21. ALARID-ESCUDERO F, Blaes AH, Kuntz KM
    Trade-offs Between Efficacy and Cardiac Toxicity of Adjuvant Chemotherapy in Early-Stage Breast Cancer Patients: Do Competing Risks Matter?
    Breast J. 2017 Jan 24. doi: 10.1111/tbj.12757.
    PubMed     Text format     Abstract available

  22. MANSFIELD SA, Abdel-Rasoul M, Terando AM, Agnese DM, et al
    Timing of Breast Cancer Surgery-How Much Does It Matter?
    Breast J. 2017 Jan 24. doi: 10.1111/tbj.12758.
    PubMed     Text format     Abstract available

  23. DUMAIS V, Lumingu J, Bedard M, Paquet L, et al
    Prevalence of Insulin Resistance, Metabolic Syndrome, and Type 2 Diabetes in Canadian Women at High Risk for Breast Cancer.
    Breast J. 2017 Jan 25. doi: 10.1111/tbj.12772.
    PubMed     Text format    

  24. DALDOUL A, Ben Ahmed K, Tlili G, Krir MW, et al
    Female Sexuality in Premenopausal Patients with Breast Cancer on Endocrine Therapy.
    Breast J. 2017 Jan 24. doi: 10.1111/tbj.12778.
    PubMed     Text format    

  25. DOWNS B, Xiao F, Kim YC, Chen PX, et al
    Single-base LOH can be used as Specific Marker to Classify BRCAx Familial Breast Cancer into More Homogenous Subtypes.
    Breast J. 2017 Jan 24. doi: 10.1111/tbj.12777.
    PubMed     Text format    

  26. ACCURSO A, Rocco N, Della Corte GA, Accardo G, et al
    Breast Cancer Surgery Under General Anesthesia: Is it Really Worth it?
    Breast J. 2017 Jan 24. doi: 10.1111/tbj.12775.
    PubMed     Text format    

  27. TAN C, Caragata R, Bennett I
    Is Sentinel Node Biopsy of the Internal Mammary Lymph Nodes Relevant in the Management of Breast Cancer?
    Breast J. 2017 Jan 24. doi: 10.1111/tbj.12754.
    PubMed     Text format     Abstract available


    Cancer

  28. FRIESE CR, Harrison JM, Janz NK, Jagsi R, et al
    Treatment-associated toxicities reported by patients with early-stage invasive breast cancer.
    Cancer. 2017 Jan 24. doi: 10.1002/cncr.30547.
    PubMed     Text format     Abstract available


    Cancer Lett

  29. BUI QT, Im JH, Jeong SB, Kim YM, et al
    Essential role of Notch4/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer.
    Cancer Lett. 2017 Jan 18. pii: S0304-3835(17)30037.
    PubMed     Text format     Abstract available

  30. RESZKA E, Przybek M, Muurlink O, Peplonska B, et al
    Circadian gene variants and breast cancer.
    Cancer Lett. 2017 Jan 18. pii: S0304-3835(17)30035.
    PubMed     Text format     Abstract available


    Cancer Res

  31. SUAREZ-CABRERA C, Quintana RM, Bravo A, Casanova ML, et al
    A transposon-based analysis reveals RASA1 is involved in triple negative breast cancer.
    Cancer Res. 2017 Jan 20. pii: canres.1586.2016.
    PubMed     Text format     Abstract available

  32. DOWER CM, Bhat N, Wang EW, Wang HG, et al
    Selective Reversible Inhibition of Autophagy in Hypoxic Breast Cancer Cells Promotes Pulmonary Metastasis.
    Cancer Res. 2016 Nov 15. doi: 10.1158/0008-5472.CAN-15-3458.
    PubMed     Text format     Abstract available

  33. WU Y, Yu X, Yi X, Wu K, et al
    Aberrant phosphorylation of SMAD4 Thr277-mediated USP9x-SMAD4 interaction by free fatty acids promotes breast cancer metastasis.
    Cancer Res. 2017 Jan 23. pii: canres.2012.2016.
    PubMed     Text format     Abstract available


    Clin Breast Cancer

  34. JONES EF, Ray KM, Li W, Seo Y, et al
    Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Clin Breast Cancer. 2016 Dec 29. pii: S1526-8209(16)30576.
    PubMed     Text format    


    Clin Cancer Res

  35. DEGNIM AC, Hoskin TL, Arshad M, Frost MH, et al
    Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development.
    Clin Cancer Res. 2017 Jan 26. pii: clincanres.2026.2016.
    PubMed     Text format     Abstract available

  36. LAMBERTS LE, Koch M, de Jong JS, Adams A, et al
    Tumor-specific uptake of fluorescent bevacizumab-IRDye800CW microdosing in patients with primary breast cancer: a phase I feasibility study.
    Clin Cancer Res. 2016 Nov 9. pii: clincanres.0437.2016.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  37. HAMILTON AM, Foster PJ
    In vivo magnetic resonance imaging investigating the development of experimental brain metastases due to triple negative breast cancer.
    Clin Exp Metastasis. 2017 Jan 21. doi: 10.1007/s10585-016-9835.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  38. LONCASTER J, Armstrong A, Howell S, Wilson G, et al
    Impact of Oncotype DX breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK.
    Eur J Surg Oncol. 2017 Jan 9. pii: S0748-7983(17)30037.
    PubMed     Text format     Abstract available


    Gene

  39. REZENDE LM, Marson FA, Lima CS, Bertuzzo CS, et al
    Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer.
    Gene. 2017 Jan 18. pii: S0378-1119(17)30032-X. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    Int J Cancer

  40. HALPERN N, Sonnenblick A, Uziely B, Divinsky L, et al
    Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30616.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  41. TRUONG PT
    Local Treatment of the Primary Tumor in Patients Presenting With Stage IV Breast Cancer: A First, and What's Up Ahead.
    Int J Radiat Oncol Biol Phys. 2017;97:443-446.
    PubMed     Text format    

  42. BOERO IJ, Gillespie EF, Hou J, Paravati AJ, et al
    The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:571-580.
    PubMed     Text format     Abstract available

  43. BELLEFQIH S, Elmajjaoui S, Aarab J, Khalil J, et al
    Hypofractionated Regional Nodal Irradiation for Women With Node-Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:563-570.
    PubMed     Text format     Abstract available


    J Clin Oncol

  44. SMITH I, Yardley D, Burris H, De Boer R, et al
    Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluat
    J Clin Oncol. 2017 Jan 23:JCO2016692871. doi: 10.1200/JCO.2016.69.2871.
    PubMed     Text format     Abstract available

  45. CHERAGHI Z, Ayubi E, Doosti-Irani A
    Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: Methodologic Issues to Avoid Misinterpretation in the Meta-Analysis.
    J Clin Oncol. 2017 Jan 23:JCO2016710715. doi: 10.1200/JCO.2016.71.0715.
    PubMed     Text format    


    J Natl Cancer Inst

  46. MAMOUNAS EP, Liu Q, Paik S, Baehner FL, et al
    21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    J Nucl Med

  47. LI L, Wu Y, Wang Z, Jia B, et al
    SPECT/CT Imaging of the Novel HER2-targeted Peptide Probe 99mTc-HYNIC-H6F in Breast Cancer Mouse Models.
    J Nucl Med. 2017 Jan 19. pii: jnumed.116.183863. doi: 10.2967/jnumed.116.183863.
    PubMed     Text format     Abstract available


    N Engl J Med

  48. THEWES B, Prins J, Friedlander M
    70-Gene Signature in Early-Stage Breast Cancer.
    N Engl J Med. 2016;375:2199-2200.
    PubMed     Text format    

  49. PLICHTA JK, Hughes K
    Radiation-Induced Angiosarcoma after Breast-Cancer Treatment.
    N Engl J Med. 2017;376:367.
    PubMed     Text format    


    NPJ Breast Cancer

  50. OH H, Eliassen AH, Wang M, Smith-Warner SA, et al
    Expression of estrogen receptor, progesterone receptor, and Ki67 in normal breast tissue in relation to subsequent risk of breast cancer.
    NPJ Breast Cancer. 2016;2.
    PubMed     Text format     Abstract available


    Oncogene

  51. YANG N, Wang C, Wang Z, Zona S, et al
    FOXM1 recruits nuclear Aurora kinase A to participate in a positive feedback loop essential for the self-renewal of breast cancer stem cells.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    Oncol Rep

  52. CAI S, Sun PH, Resaul J, Shi L, et al
    Expression of phospholipase C isozymes in human breast cancer and their clinical significance.
    Oncol Rep. 2017 Jan 20. doi: 10.3892/or.2017.5394.
    PubMed     Text format     Abstract available

  53. WANG N, Wei L, Huang Y, Wu Y, et al
    miR520c blocks EMT progression of human breast cancer cells by repressing STAT3.
    Oncol Rep. 2017 Jan 19. doi: 10.3892/or.2017.5393.
    PubMed     Text format     Abstract available


    Oncology

  54. KIESEWETTER B, Lukas J, Dolak W, Simonitsch-Klupp I, et al
    Gender Aspects in Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue: Does Sex Matter?
    Oncology. 2016.
    PubMed     Text format     Abstract available

  55. SNIDER 3RD JW, Mutaf Y, Nichols E, Hall A, et al
    Dosimetric Improvements with a Novel Breast Stereotactic Radiotherapy Device for Delivery of Preoperative Partial-Breast Irradiation.
    Oncology. 2017;92:21-30.
    PubMed     Text format     Abstract available


    PLoS One

  56. ZIV E, Tice JA, Sprague B, Vachon CM, et al
    Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention.
    PLoS One. 2017;12:e0168601.
    PubMed     Text format     Abstract available

  57. PIRES BR, Mencalha AL, Ferreira GM, de Souza WF, et al
    NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells.
    PLoS One. 2017;12:e0169622.
    PubMed     Text format     Abstract available

  58. DALM SU, Schrijver WA, Sieuwerts AM, Look MP, et al
    Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer.
    PLoS One. 2017;12:e0170536.
    PubMed     Text format     Abstract available

  59. YIN K, Liu Y, Chu M, Wang Y, et al
    TFDP3 Regulates Epithelial-Mesenchymal Transition in Breast Cancer.
    PLoS One. 2017;12:e0170573.
    PubMed     Text format     Abstract available

  60. DENG J, Yang M, Jiang R, An N, et al
    Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.
    PLoS One. 2017;12:e0170860.
    PubMed     Text format     Abstract available

  61. SIGLEY J, Jarzen J, Scarpinato K, Guthold M, et al
    Diffusion and Binding of Mismatch Repair Protein, MSH2, in Breast Cancer Cells at Different Stages of Neoplastic Transformation.
    PLoS One. 2017;12:e0170414.
    PubMed     Text format     Abstract available

  62. PETERS IT, van Zwet EW, Smit VT, Liefers GJ, et al
    Prevalence and Risk Factors of Ovarian Metastases in Breast Cancer Patients < 41 Years of Age in the Netherlands: A Nationwide Retrospective Cohort Study.
    PLoS One. 2017;12:e0168277.
    PubMed     Text format     Abstract available

  63. PILLAI SG, Zhu P, Siddappa CM, Adams DL, et al
    Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration.
    PLoS One. 2017;12:e0170761.
    PubMed     Text format     Abstract available


    Pol J Radiol

  64. AYAZ S, Gultekin SS, Ayaz UY, Dilli A, et al
    Initial Fludeoxyglucose (18F) Positron Emission Tomography-Computed Tomography (FDG-PET/CT) Imaging of Breast Cancer - Correlations with the Primary Tumour and Locoregional Metastases.
    Pol J Radiol. 2017;82:9-16.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: